CN1724043A - Oral soup for treating heart or brain diseases - Google Patents
Oral soup for treating heart or brain diseases Download PDFInfo
- Publication number
- CN1724043A CN1724043A CN 200410012414 CN200410012414A CN1724043A CN 1724043 A CN1724043 A CN 1724043A CN 200410012414 CN200410012414 CN 200410012414 CN 200410012414 A CN200410012414 A CN 200410012414A CN 1724043 A CN1724043 A CN 1724043A
- Authority
- CN
- China
- Prior art keywords
- adjuvant
- cardio
- cerebral diseases
- oral liquid
- correctives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A Chinese medicine in the form of oral liquid for treating cardiac and cerebral diseases is an improvement on existing Chinese medicine 'Shengmaiyin' in that original cane sugar is replaced by the non-sugar flavouring to prevent the increasing of blood sugar.
Description
Technical field
The present invention relates to a kind of oral medicine for the treatment of cardio-cerebral diseases, particularly is the improvement to the cardio-cerebral diseases pharmaceutical formulation of a kind of " SHENGMAI YIN KOUFUYE " by name.
Prior art
" SHENGMAI YIN KOUFUYE " reaches " SHENGMAI YIN syrup " is a kind of Chinese patent medicine for the treatment of cardio-cerebral diseases, and it is evident in efficacy.Prescription closes at pharmacopeia, and records in OTC, is decided to be nonprescription drugs.Use the cardio-cerebral diseases patient of this medicine, considerable part is low person of function carbohydrate metabolism and diabetics, and is very responsive to the absorption of sugar.Because existing " SHENGMAI YIN KOUFUYE " reaches in the prescription of " SHENGMAI YIN syrup ", except that principal agent Radix Ginseng or Radix Codonopsis and Radix Ophiopogonis, Fructus Schisandrae Chinensis, its adjuvant is a correctives sucrose.Obviously be not suitable for diabetics.So existing " SHENGMAI YIN " is though be decided to be prescription drugs, producer still has to emphasize " diabetics should be taken " under the doctor instructs at the operation instructions of this medicine, thereby not only increased the insecurity of OTC medicine, more increase the patient's who uses this medicine psychological burden, directly influenced the performance of curative effect of medication and patient's health.
Summary of the invention
The present invention is exactly a kind of oral liquid medicine for the treatment of cardio-cerebral diseases of inventing at the significant deficiency of existing " SHENGMAI YIN KOUFUYE " existence, this medicine is made up of principal agent and accessory drugs, the principal agent raw material is counted by weight ratio: Radix Ginseng 1-2 part or Radix Codonopsis 1-4 part reach 1-4 part Radix Ophiopogonis, Fructus Schisandrae Chinensis 0.5-2 part; Adjuvant is correctives sugar alcohols 2.5-5 part, or stevioside 0.0001-0.02 part, or aspartame 0.0001-0.02 part, or glucide 0.0001-0.02 part, or citric acid 0.0001-0.02 part, or sodium chloride 0.001-0.01 part and water 3-5 part.
The present invention has kept the principal agent composition of existing Chinese patent medicine " SHENGMAI YIN ", has removed the sucrose in the former medicine adjuvant, and has replaced diabetics harmless useful sweet taste adjuvant or Sal.Taking this medicine will not increase patient's pancreas and lead plain consumption, the blood glucose value that more can not raise, thus eliminated the psychological burden and the insecurity of diabetics fully, make this medicine become genuine nonprescription drugs.The present invention has carried out correction, improvement to the pharmacopeia long-standing significant deficiency of writing out a prescription, and its prescription is unaffected fully to the therapeutical effect of cardio-cerebral diseases.
The specific embodiment
Embodiment 1, with Radix Ginseng 1000 gram, Radix Ophiopogonis 4000 gram, Fructus Schisandrae Chinensis 500 grams be ground into coarse powder, according to the percolation under the fluid extract item, 65% ethanol is made solvent, floods to carry out percolation after 24 hours, collects the about 49500ml of liquid that filters, be evaporated to 2750ml, put coldly, add water 4400ml dilution, filter, other adds and contains 70% xylitol slurry 3300ml and an amount of antiseptic, and regulate the Ph value to prescribed limit, and adjust total amount as for 11000ml, stir evenly, leave standstill, filter, embedding, sterilization promptly gets Radix Ginseng side's SHENGMAI YIN KOUFUYE.
Embodiment 2, with Radix Ginseng 2000 gram, Radix Ophiopogonis 1000 gram, Fructus Schisandrae Chinensis 2000 grams and sweetleaf glycosides or aspartame 10 grams prepare Radix Ginseng side's SHENGMAI YIN KOUFUYE by embodiment 1 method.
Embodiment 3, with Radix Codonopsis 4000 gram, Radix Ophiopogonis 3000 gram, Fructus Schisandrae Chinensis 1000 grams and glucide 15 grams press embodiment 1 side and prepare Radix Codonopsis side's SHENGMAI YIN KOUFUYE.
Embodiment 4, with Radix Codonopsis 1000 gram, Radix Ophiopogonis 1500 gram, Fructus Schisandrae Chinensis 1500 grams and glucide 10 grams, citric acid 5 restrain and be equipped with Radix Codonopsis side's SHENGMAI YIN KOUFUYE.
Embodiment 5, with Radix Codonopsis 1000 gram, Radix Ophiopogonis 2500 gram, Fructus Schisandrae Chinensis 600 and sodium chloride 10 grams prepare Radix Codonopsis side's SHENGMAI YIN KOUFUYE by embodiment 1 method.
Claims (4)
1, a kind of oral liquid medicine for the treatment of cardio-cerebral diseases is made up of principal agent and adjuvant, and its principal agent raw material weight proportioning is: Radix Ginseng 1-2 part or Radix Codonopsis 1-4 part, reach 1-4 part Radix Ophiopogonis, Fructus Schisandrae Chinensis 0.5-2 part, and its adjuvant is correctives sugar alcohols 2.5-5 part and water 3-5 part.
2, the oral liquid medicine of treatment cardio-cerebral diseases according to claim 1 is characterized in that said adjuvant correctives is that weight ratio is the stevioside or the aspartame of 0.0001-0.02 part.
3, according to the oral liquid medicine of the treatment cardio-cerebral diseases of claim 1 art, it is characterized in that said adjuvant correctives is that weight ratio is the glucide or and the citric acid of 0.0001-0.02 part.
4, the oral liquid medicine of treatment cardio-cerebral diseases according to claim 1 is characterized in that said adjuvant correctives is that weight ratio is the sodium chloride of 0.001-0.01 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410012414 CN1724043A (en) | 2004-07-20 | 2004-07-20 | Oral soup for treating heart or brain diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410012414 CN1724043A (en) | 2004-07-20 | 2004-07-20 | Oral soup for treating heart or brain diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1724043A true CN1724043A (en) | 2006-01-25 |
Family
ID=35923761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410012414 Pending CN1724043A (en) | 2004-07-20 | 2004-07-20 | Oral soup for treating heart or brain diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1724043A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102450718A (en) * | 2010-10-29 | 2012-05-16 | 钟虹光 | Pulse sports beverage and preparation method thereof |
| CN112263643A (en) * | 2020-11-26 | 2021-01-26 | 太极集团·四川天诚制药有限公司 | Pulse activating beverage without sucrose and preservative and preparation method thereof |
-
2004
- 2004-07-20 CN CN 200410012414 patent/CN1724043A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102450718A (en) * | 2010-10-29 | 2012-05-16 | 钟虹光 | Pulse sports beverage and preparation method thereof |
| CN102450718B (en) * | 2010-10-29 | 2013-05-08 | 钟虹光 | Pulse sports beverage and preparation method thereof |
| CN112263643A (en) * | 2020-11-26 | 2021-01-26 | 太极集团·四川天诚制药有限公司 | Pulse activating beverage without sucrose and preservative and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9345735B2 (en) | Fenugreek seed extract to lower blood cholesterol | |
| CN101700365A (en) | Functional beverage for improving vision | |
| CN106509261A (en) | Sugar-free herbal tea plant composition, and method for preparing drink and granule from composition | |
| US20110104290A1 (en) | Compositions for reducing blood glucose level and uses thereof | |
| CN108524673A (en) | A kind of Chinese medicine composition and its application | |
| US5482712A (en) | Galenic composition | |
| CN101507800A (en) | Ludisia discolor and pumpkin composite health care product capable of reducing blood sugar and preparation method thereof | |
| CN104041900A (en) | Alcohol-effect-dispelling and health-maintaining plant beverage and preparation method thereof | |
| CN106723029A (en) | A kind of health food and its preparation technology with auxiliary hyperglycemic function | |
| CN104474472B (en) | Buccal lozenge of lectuce tea and its production method with three high drop effect | |
| CN102885975A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN112970992A (en) | Solid beverage suitable for diabetes patients and preparation method thereof | |
| CN107998240A (en) | A kind of formula for the fatigue-relieving clearing health care buccal tablets that refresh the mind and preparation method thereof | |
| CN102784191B (en) | Phyllanthus emblica syrup composition and preparation method thereof | |
| CN101254263A (en) | Compound Japanese polygala oral liquid and method of preparing the same | |
| KR20010105095A (en) | Antidiabetic composition and food containing the same | |
| CN111135235A (en) | A composition for preventing and relieving acute alcoholism or alcoholic intoxication | |
| CN106214787B (en) | A kind of Chinese medicine composition for treating diabetes and preparation method thereof and purposes | |
| CN102784215B (en) | Snow pear cough-relieving syrup and preparation method | |
| CN110856549A (en) | Sugar-free functional food and preparation method thereof | |
| CN1724043A (en) | Oral soup for treating heart or brain diseases | |
| CN108379500B (en) | Wheat seedling traditional Chinese medicine composition for nourishing liver, dispelling effects of alcohol, sobering up and preventing halitosis and preparation method thereof | |
| CN103271402B (en) | Functional beverage for reducing blood sugar | |
| CN102973657B (en) | Cough-relieving Qinbaohong mixture and preparation method thereof | |
| CN102949681B (en) | Composition for preventing or treating colds, and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |